The Use of Empagliflozin Post Myocardial Infarction

Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor that is mainly used for the treatment of type 2 diabetes mellitus. The study's objective was to assess empagliflozin's effects and impacts on post-myocardial patients to highlight its worth in comparison to alternative the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravendran, Kapilraj, Madouros, Nikolaos, Yoztyurk, Edzhem, Wilson, Aishwarya, Jeejo, Maria J, Camelio, Monica E, Sinha, Akatya, George, Ananya, Rai, Mriganka, Malik, Hussain K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353858/
https://www.ncbi.nlm.nih.gov/pubmed/37469808
http://dx.doi.org/10.7759/cureus.40602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353858/
https://www.ncbi.nlm.nih.gov/pubmed/37469808
http://dx.doi.org/10.7759/cureus.40602

Ejemplares similares